Abstract
Squamous cell carcinoma of the lung ranks as one of the most prevalent and lethal of all malignancies. Though bronchogenic carcinoma responds to both chemotherapy [10] and radiotherapy, the survival of lung cancer patients has not greatly increased, and cure is anticipated only when complete surgical resection is possible; under actual therapeutical conditions, no more than 7.5–10% of patients with squamous cell carcinoma of the lung can be cured, and chemotherapy systematically applied after surgery has been demonstrated as ineffective [1, 11].
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Brunner, K. W., Marhaler, T. H., Muller, W.: Unfavorable effects of long term adjuvant chemotherapy with endoxan in radically operated bronchogenic carcinoma. Europ. J. Cancer 7, 285–288 (1971).
Decroix, J.: Personal communication.
Eilber, F. R., Morton, D. L.: Impaired immunologic reactivity and recurrence following cancer surgery. Cancer 25, 362, 367 (1970).
Israel, L., Mugica, J., Cha Inian, P.: Prognosis of early bronchogenic carcinoma. Survival curves of 451 patients after resection of lung cancer in relation to the results of preoperative tuberculin skin tests. Biomedicine 19, 68–71 (1973).
Mathé, G., Amiel, J. L., Schwarzenberg, L., Cattan, A., Schlumberger, J. R., Hayat, M., de Vassal, F.: Active immunotherapy for acute lymphoid leukemia. Lancet (1969) I, 697–699.
Mathé, G., Pouillart, P., Lapeyraque, F.: Active immunotherapy of L1210 leukemia applied after the graft of tumor cell. Brit. J. Cancer 23, 814–816 (1969).
Mathé, G., Pouillart, P., Schwarzenberg, L., Amiel, J. L., Schneider, M., Hayat, M., de Vassal, F., Jasmin, C., Rosenfeld, C., Weiner, R., Rappaport, H.: Attempt at immunotherapy of 100 acute lymphoid leukemia patients. Some factors influencing results. Nat. Cancer Inst. 35, 361–371 (1972).
Morton, D. L., Eilber, F. R., Marmgren, R. A., Wood, W.: Immunological factors which influence response to immunotherapy in malignant melanoma. Surgery 68, 158–164 (1970).
Pouillart, P., Botto, G., Gautier, H., Huguenin, P., Baron, A., Laparre, C., Hoang Thy, H. T., Parrot, R., Mathé, G.: Relation entre l’état immunitaire et la réponse à la chimiothérapie. Résultats chez 64 malades avec cancers bronchiques epidermoides inopérables. Nouv. Presse Med. 5, 1037–1042 (1976).
Pouillart, P., Schwarzenberg, L., Amiel, J. L., Mathé, G., Huguenin, P., Morin, P., Baron, A., Laparre, C., Parrot, C.: Combinaisons de drogues se potentialisant. 1. Application au traitement des cancers du sein. 2. Application au traitement des cancers des bronches. 3. Application au traitement des tumeurs primitives du système nerveux central. Nouv. Presse Med. 4, 713–716 (1975).
Selawry, O. S., Hansen, H. H.: Lung cancer in “cancer treatment.” Holland, J., Frei, E., III (eds.). Philadelphia: Lea and Febiger, 1974.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1977 Springer-Verlag Berlin · Heidelberg
About this chapter
Cite this chapter
Pouillart, P. et al. (1977). Trial of BCG Immunotherapy in the Treatment of Resectable Squamous Cell Carcinoma of the Bronchus (Stages I and II). In: Mathé, G. (eds) Tactics and Strategy in Cancer Treatment. Recent Results in Cancer Research / Fortschritte der Krebsforschung / Progrès dans les recherches sur le cancer, vol 62. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-81174-6_22
Download citation
DOI: https://doi.org/10.1007/978-3-642-81174-6_22
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-81176-0
Online ISBN: 978-3-642-81174-6
eBook Packages: Springer Book Archive